Artificial intelligence in myeloproliferative neoplasms: From digital bone marrow pathology to clinical decision support
Study limitation reported by the research below: “No AI tool reviewed has been prospectively validated to change clinical decision-making or improve patient outcomes in MPN — predictive accuracy should not be equated with clinical utility.”